ArticleMolecules (Basel, Switzerland)2021

Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment.

Amin Osman ElzupirPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.